These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20569484)

  • 1. Neutrophil mediated smooth muscle cell loss precedes allograft vasculopathy.
    King CL; Devitt JJ; Lee TD; Hancock Friesen CL
    J Cardiothorac Surg; 2010 Jun; 5():52. PubMed ID: 20569484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophils are responsible for impaired medial smooth muscle cell recovery and exaggerated allograft vasculopathy in aortic allografts exposed to prolonged cold ischemia.
    So M; Lee TD; Hancock Friesen CL
    J Heart Lung Transplant; 2013 Mar; 32(3):360-7. PubMed ID: 23415317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early innate immune events induced by prolonged cold ischemia exacerbate allograft vasculopathy.
    Devitt JJ; King CL; Lee TD; Hancock Friesen CL
    J Cardiothorac Surg; 2011 Jan; 6():2. PubMed ID: 21211039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of B cells and antibody to cardiac allograft vasculopathy.
    Gareau A; Hirsch GM; Lee TD; Nashan B
    Transplantation; 2009 Aug; 88(4):470-7. PubMed ID: 19696629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy.
    Gareau AJ; Nashan B; Hirsch GM; Lee TD
    J Heart Lung Transplant; 2012 Aug; 31(8):874-80. PubMed ID: 22554675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common protective and diverse smooth muscle cell effects of AAV-mediated angiopoietin-1 and -2 expression in rat cardiac allograft vasculopathy.
    Nykänen AI; Pajusola K; Krebs R; Keränen MA; Raisky O; Koskinen PK; Alitalo K; Lemström KB
    Circ Res; 2006 Jun; 98(11):1373-80. PubMed ID: 16690881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Inhibition of Vanin Activity Attenuates Transplant Vasculopathy in Rat Aortic Allografts.
    Wedel J; Jansen PA; Botman PN; Rutjes FP; Schalkwijk J; Hillebrands JL
    Transplantation; 2016 Aug; 100(8):1656-66. PubMed ID: 27014792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of thymectomy on tolerance induction and cardiac allograft vasculopathy in a miniature swine heart/kidney transplantation model.
    Yamada K; Choo JK; Allan JS; Erhorn AE; Menard MT; Mawulawde K; Slisz JK; Aretz HT; Shimizu A; Sachs DH; Madsen JC
    Transplantation; 1999 Aug; 68(4):485-91. PubMed ID: 10480404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune mechanisms in transplant allograft vasculopathy.
    Jane-Wit D; Fang C; Goldstein DR
    Curr Opin Organ Transplant; 2016 Jun; 21(3):253-7. PubMed ID: 27077602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smooth muscle cells clonally expand in a murine carotid allograft model complicated by immune reactions to reporter transgenes.
    Pløen GG; Sørensen CB; Bentzon JF
    Transpl Immunol; 2024 Dec; 87():102129. PubMed ID: 39260676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medial smooth muscle cell loss in arterial allografts occurs by cytolytic cell induced apoptosis.
    Hirsch GM; Kearsey J; Burt T; Karnovsky MJ; Lee T
    Eur J Cardiothorac Surg; 1998 Jul; 14(1):89-96; discussion 96-7. PubMed ID: 9726621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma and Fas/FasL pathways cooperate to induce medial cell loss and neointimal lesion formation in allograft vasculopathy.
    Hart-Matyas M; Nejat S; Jordan JL; Hirsch GM; Lee TD
    Transpl Immunol; 2010 Feb; 22(3-4):157-64. PubMed ID: 19895889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis.
    El-Sawy T; Miura M; Fairchild R
    Am J Pathol; 2004 Jul; 165(1):147-57. PubMed ID: 15215170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation.
    Atkinson C; He S; Morris K; Qiao F; Casey S; Goddard M; Tomlinson S
    J Immunol; 2010 Dec; 185(11):7007-13. PubMed ID: 20962256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection.
    El-Sawy T; Belperio JA; Strieter RM; Remick DG; Fairchild RL
    Circulation; 2005 Jul; 112(3):320-31. PubMed ID: 15998678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
    Koglin J
    Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.
    Nykänen AI; Krebs R; Tikkanen JM; Raisky O; Sihvola R; Wood J; Koskinen PK; Lemström KB
    Transplantation; 2005 Jan; 79(2):182-9. PubMed ID: 15665766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived Growth Factor-B Protects Rat Cardiac Allografts From Ischemia-reperfusion Injury.
    Tuuminen R; Dashkevich A; Keränen MA; Raissadati A; Krebs R; Jokinen JJ; Arnaudova R; Rouvinen E; Ylä-Herttuala S; Nykänen AI; Lemström KB
    Transplantation; 2016 Feb; 100(2):303-13. PubMed ID: 26371596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation.
    Li W; Feng G; Gauthier JM; Lokshina I; Higashikubo R; Evans S; Liu X; Hassan A; Tanaka S; Cicka M; Hsiao HM; Ruiz-Perez D; Bredemeyer A; Gross RW; Mann DL; Tyurina YY; Gelman AE; Kagan VE; Linkermann A; Lavine KJ; Kreisel D
    J Clin Invest; 2019 Feb; 129(6):2293-2304. PubMed ID: 30830879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection.
    Morita K; Miura M; Paolone DR; Engeman TM; Kapoor A; Remick DG; Fairchild RL
    J Immunol; 2001 Sep; 167(5):2979-84. PubMed ID: 11509648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.